StocksMediumUpdated•Originally published 13 November 2026•Updated 13 November 2026•
1 min read
SBC Medical Shares Surge 12% Following Strong Q3 Results
Key Facts
1SBC Medical shares surged 12% following the announcement of strong Q3 2026 financial results.
SBC Medical shares surged 12% following the announcement of strong Q3 2026 financial results. The company reported revenue of $58.6 million, while GAAP net income rose to $16.4 million, representing earnings of $0.15 per share.
Investors responded to figures showing a 35% revenue increase and a 66% surge in Adjusted EBITDA. SBC was trading at $5.34 on November 12, 2026, prior to the release of the results which exceeded market expectations.